Macitentan and pulmonary arterial hypertension

Comment

Tomás Pulido et al. N Engl J Med. 2014.

. 2014 Jan 2;370(1):82-3.

doi: 10.1056/NEJMc1313112.

No abstract available

Comment on

Macitentan and morbidity and mortality in pulmonary arterial hypertension.
Pulido T, Adzerikho I, Channick RN, Delcroix M, Galiè N, Ghofrani HA, Jansa P, Jing ZC, Le Brun FO, Mehta S, Mittelholzer CM, Perchenet L, Sastry BK, Sitbon O, Souza R, Torbicki A, Zeng X, Rubin LJ, Simonneau G; SERAPHIN Investigators. Pulido T, et al. N Engl J Med. 2013 Aug 29;369(9):809-18. doi: 10.1056/NEJMoa1213917. N Engl J Med. 2013. PMID: 23984728 Clinical Trial.
Macitentan and pulmonary arterial hypertension.
Anderson TS, Good CB, Gellad WF. Anderson TS, et al. N Engl J Med. 2014 Jan 2;370(1):81. doi: 10.1056/NEJMc1313112. N Engl J Med. 2014. PMID: 24382072 No abstract available.
Macitentan and pulmonary arterial hypertension.
Tonelli AR, Dweik RA. Tonelli AR, et al. N Engl J Med. 2014 Jan 2;370(1):81-2. doi: 10.1056/NEJMc1313112. N Engl J Med. 2014. PMID: 24382073 No abstract available.
Macitentan and pulmonary arterial hypertension.
Macchia A, Mariani J, Tognoni G. Macchia A, et al. N Engl J Med. 2014 Jan 2;370(1):82. doi: 10.1056/NEJMc1313112. N Engl J Med. 2014. PMID: 24382074 No abstract available.